The Anti-Infective Innovator Blog

Spero Therapeutics Raises $30M Series A, Plans Antibiotic Clinical Trials in 2016

Spero Therapeutics Raises $30M Series A, Plans Antibiotic Clinical Trials in 2016

The Anti-Infective Innovator Blog
Posted on
October 30, 2017
Written by Spero Therapeutics,
Dow Jones

Sign up to receive news and announcements.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.